Effect of a Short-Time Probiotic Supplementation on the Abundance of the Main Constituents of the Gut Microbiota of Term Newborns Delivered by Cesarean Section—A Randomized, Prospective, Controlled Clinical Trial

The gut microbiota plays a pivotal role in the maintenance of human health. Numerous factors, including the mode of delivery, impact early gut colonization in newborns. Recent research focuses on the use of probiotics in the prevention of gut dysbiosis in newborns delivered by cesarean section (CS). The objective of this study was to determine whether a probiotic supplement given to newborns delivered by CS during their stay in the maternity ward alters the pattern of early gut colonization by lactic acid bacteria versus potential pathogens. A prospective, randomized trial was conducted. In total, 150 newborns, born at 38–40 weeks gestational age and delivered by CS, were included in the study. They were randomized into the intervention group, supplemented orally with a probiotic containing Bifidobacterium breve PB04 and Lactobacillus rhamnosus KL53A, and the control group. Stool samples were obtained on days 5 and 6 of life and after one month of life and were analyzed for the presence and abundance of the main groups of bacteria. An application of two probiotic bacteria during the first days of life after CS resulted in quick and abundant colonization by days 5 and 6, with high populations of L. rhamnosus and B. breve. The applied bacterial strains were present in the majority of neonates one month after. The supplementation of term neonates delivered by cesarean section immediately after birth with a mixture of L. rhamnosus and B. breve enriched the gut microbiota composition with lactic acid bacteria.

[1]  P. Heczko,et al.  Coagulase-Negative Staphylococci Contained in Gut Microbiota as a Primary Source of Sepsis in Low- and Very Low Birth Weight Neonates , 2020, Journal of clinical medicine.

[2]  P. Heczko,et al.  Neonate Bloodstream Infections in Organization for Economic Cooperation and Development Countries: An Update on Epidemiology and Prevention , 2019, Journal of clinical medicine.

[3]  D. Yusef,et al.  Community-acquired serious bacterial infections in the first 90 days of life: a revisit in the era of multi-drug-resistant organisms , 2019, World Journal of Pediatrics.

[4]  M. Szczepanski,et al.  Effects of oral probiotic supplementation on gut Lactobacillus and Bifidobacterium populations and the clinical status of low-birth-weight preterm neonates: a multicenter randomized, double-blind, placebo-controlled trial , 2018, Infection and drug resistance.

[5]  K. Okoń,et al.  Lactobacilli with superoxide dismutase-like or catalase activity are more effective in alleviating inflammation in an inflammatory bowel disease mouse model , 2018, Drug design, development and therapy.

[6]  A. Benson,et al.  Experimental evaluation of the importance of colonization history in early-life gut microbiota assembly , 2018, eLife.

[7]  A. Waligora-Dupriet,et al.  The developing gut microbiota and its consequences for health , 2018, Journal of Developmental Origins of Health and Disease.

[8]  F. Bloomfield,et al.  Factors Affecting Gastrointestinal Microbiome Development in Neonates , 2018, Nutrients.

[9]  J. Walter,et al.  Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome. , 2017, The American journal of clinical nutrition.

[10]  J. Torres,et al.  Development of Microbiota in Infants and its Role in Maturation of Gut Mucosa and Immune System. , 2017, Archives of medical research.

[11]  M. Kleerebezem,et al.  Intestinal colonisation patterns in breastfed and formula-fed infants during the first 12 weeks of life reveal sequential microbiota signatures , 2017, Scientific Reports.

[12]  Y. Yamashiro,et al.  Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section , 2016, Front. Microbiol..

[13]  B. Berger,et al.  Effect of Formula Containing Lactobacillus reuteri DSM 17938 on Fecal Microbiota of Infants Born by Cesarean-Section , 2016, Journal of pediatric gastroenterology and nutrition.

[14]  A. Field,et al.  Association Between Cesarean Birth and Risk of Obesity in Offspring in Childhood, Adolescence, and Early Adulthood. , 2016, JAMA pediatrics.

[15]  F. Tao,et al.  The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review , 2016, BMC Gastroenterology.

[16]  Omry Koren,et al.  Microbial Changes during Pregnancy, Birth, and Infancy , 2016, Front. Microbiol..

[17]  C. C. Johnson,et al.  Combined effects of prenatal medication use and delivery type are associated with eczema at age 2 years , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  M. Moffatt,et al.  Dysbiosis Anticipating Necrotizing Enterocolitis in Very Premature Infants , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  H. Won,et al.  Additive Effect between IL-13 Polymorphism and Cesarean Section Delivery/Prenatal Antibiotics Use on Atopic Dermatitis: A Birth Cohort Study (COCOA) , 2014, PloS one.

[20]  M. Rojas,et al.  Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm Infants , 2012, Pediatrics.

[21]  P. Heczko,et al.  Critical evaluation of probiotic activity of lactic acid bacteria and their effects. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.